Skip to content
Search

Latest Stories

India's ailing finance minister Arun Jaitley quits government

INDIA'S influential but ailing finance minister Arun Jaitley announced today (29) that he would not serve in prime minister Narendra Modi's new government because of his poor health.

Modi is set to be sworn in Thursday (30) after winning a second landslide election and should name his new cabinet shortly after.


Jaitley, 66, a key member of the last government, said in a letter to Modi he released on Twitter that he would "like to keep away from any responsibility" so he could concentrate on his health and treatment.

Jaitley underwent a kidney transplant in May last year and in February travelled to the US for surgery after being diagnosed with cancer.

"I am writing to you to formally request you that I should be allowed a reasonable time for myself, my treatment and my health and therefore not be a part of any responsibility, for the present, in the new government," he added in the letter.

Jaitley also hailed the "spectacular win" of Modi's right Bharatiya Janata Party (BJP) in the six-week election that ended last week.

The BJP swept 303 of the 542 contested parliamentary seats to win a second five-year term.

A lawyer-turned-politician, Jaitley guided the government's rollout of a complex nationwide tax and often acted as a spokesman on contentious issues.

Railways minister Piyush Goyal, who stepped in for Jaitley to present an interim budget in February, and BJP president Amit Shah are in contention for Jaitley's job, media reports said.

India is the world's sixth largest economy and although it has been growing at about seven per cent a year, it is showing signs of a slowdown.

Modi, 68, has invited the heads of countries who are in the Bay of Bengal Initiative for Maritime and Economic Co-operation (BIMSTEC) to the swearing-in.

India's neighbour Pakistan is not a part of the alliance and so Modi avoided inviting Pakistan prime minister Imran Khan.

(AFP)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less